Lucioni, C., Mazzi, S., & Caporali, R. (2015). Budget impact analysis of infliximab biosimilar: the Italian scenery: Analisi di budget impact del biosimilare di infliximab: lo scenario italiano. Global and Regional Health Technology Assessment, 2(2), 78–88. https://doi.org/10.33393/grhta.2015.330